Advanced search
Publication Cover
Current Medical Research and Opinion Volume 25, 2009 - Issue 1
Submit an article Journal homepage
293
Views
47
CrossRef citations to date
0
Altmetric
Original Article

Retrospective study of the association between transfusion frequency and potential complications of iron overload in patients with myelodysplastic syndrome and other acquired hematopoietic disorders*

Thomas E. Delea Policy Analysis Inc. (PAI), Brookline, MA, USACorrespondence[email protected]
,
May Hagiwara Policy Analysis Inc. (PAI), Brookline, MA, USA
&
Pradyumna D. Phatak Hematology/Oncology Unit, Rochester General Hospital, Rochester, NY, USA
Pages 139-147 | Accepted 20 Oct 2008, Published online: 08 Dec 2008

References

  • Kushner JP, Porter JP, Olivieri NF. Secondary iron overload. Hematology (Am Soc Hematol Educ Program) 2001;47-61
  • Gabutti V, Piga A. Results of long-term iron-chelating therapy. Acta Haematol 1996;95:26-36
  • Brittenham GM, Griffith PM, Nienhuis AW, et al. Efficacy of deferoxamine in preventing complications of iron overload in patients with thalassemia major. N Engl J Med 1994;331:567-73
  • Olivieri NF, Nathan DG, MacMillan JH, et al. Survival in medically treated patients with homozygous β-thalassemia. N Engl J Med 1994;331:574-8
  • Malcovati L, Della Porta MG, Pascutto C, et al. The effect of transfusion dependency and secondary iron overload on survival of patients with myelodysplastic syndrome. [abstract]. Blood 2005;106:233-4a
  • Delea TE, Hagiwara M, Thomas SK, et al. Utilization of transfusions and iron chelation therapy in patients with myelodysplastic syndromes. 3rd International Congress of Myeloproliferative Diseases and Myelodysplastic Syndromes, Washington, DC, October 27-29, 2005. Abstract 42
  • Melchert M, List A.Targeted therapies in myelodysplastic syndrome. Semin Hematol 2008;45:31-8
  • Deyo RA, Cherkin DC, Ciol MA.Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases. J Clin Epidemiol 1992;45:613-19
  • Stokes ME, Davis CS, Koch GG. Categorical Data Analysis Using the SAS® System, 2nd edn, Cary NC: SAS Institute Inc., 2000
  • Malcovati L, Porta MG, Pascutto C, et al. Prognostic factors and life expectancy in myelodysplastic syndromes classified according to WHO criteria: a basis for clinical decision making. J Clin Oncol 2005;23:7594-603. Epub 2005 Sep 26
  • Takatoku M, Uchiyama T, Okamoto S, et al. Retrospective nationwide survey of Japanese patients with transfusion-dependent MDS and aplastic anemia highlights the negative impact of iron overload on morbidity/mortality. Eur J Haematol 2007;78:487-94. Epub 2007 Mar 28
  • Chacko J, Pennell DJ, Tanner MA, et al. Myocardial iron loading by magnetic resonance imaging T2* in good prognostic myelodysplastic syndrome patients on long-term blood transfusions. Br J Haematol 2007;138:587-93. Epub 2007 Jul 4

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.